Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lansoprazol - enterokapsler, hårde - 15 mg

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150 mg/400 mg/75 mg

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - lansoprazol - enterokapsler, hårde - 15 mg

Europese Unie - Deens - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europese Unie - Deens - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Europese Unie - Deens - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - lansoprazol - enterokapsler, hårde - 15 mg

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg